Your browser doesn't support javascript.
Montrer: 20 | 50 | 100
Résultats 1 - 2 de 2
Filtre
Ajouter des filtres

Base de données
Les sujets
Année
Type de document
Gamme d'année
1.
J Appl Lab Med ; 7(5): 1025-1036, 2022 09 01.
Article Dans Anglais | MEDLINE | ID: covidwho-1901198

Résumé

BACKGROUND: To support the implementation of high-throughput pipelines suitable for SARS-CoV-2 sequencing and analysis in a clinical laboratory, we developed an automated sample preparation and analysis workflow. METHODS: We used the established ARTIC protocol with approximately 400 bp amplicons sequenced on Oxford Nanopore's MinION. Sequences were analyzed using Nextclade, assigning both a clade and quality score to each sample. RESULTS: A total of 2179 samples on twenty-five 96-well plates were sequenced. Plates of purified RNA were processed within 12 h, sequencing required up to 24 h, and analysis of each pooled plate required 1 h. The use of samples with known threshold cycle (Ct) values enabled normalization, acted as a quality control check, and revealed a strong correlation between sample Ct values and successful analysis, with 85% of samples with Ct < 30 achieving a "good" Nextclade score. Less abundant samples responded to enrichment with the fraction of Ct > 30 samples achieving a "good" classification rising by 60% after addition of a post-ARTIC PCR normalization. Serial dilutions of 3 variant of concern samples, diluted from approximately Ct = 16 to approximately Ct = 50, demonstrated successful sequencing to Ct = 37. The sample set contained a median of 24 mutations per sample and a total of 1281 unique mutations with reduced sequence read coverage noted in some regions of some samples. A total of 10 separate strains were observed in the sample set, including 3 variants of concern prevalent in British Columbia in the spring of 2021. CONCLUSIONS: We demonstrated a robust automated sequencing pipeline that takes advantage of input Ct values to improve reliability.


Sujets)
COVID-19 , Séquençage par nanopores , Nanopores , COVID-19/diagnostic , COVID-19/épidémiologie , Humains , Reproductibilité des résultats , SARS-CoV-2/génétique
2.
J Virol Methods ; 299: 114339, 2022 01.
Article Dans Anglais | MEDLINE | ID: covidwho-1472084

Résumé

The COVID-19 pandemic has highlighted the need for generic reagents and flexible systems in diagnostic testing. Magnetic bead-based nucleic acid extraction protocols using 96-well plates on open liquid handlers are readily amenable to meet this need. Here, one such approach is rigorously optimized to minimize cross-well contamination while maintaining sensitivity.


Sujets)
COVID-19 , Acides nucléiques , Dépistage de la COVID-19 , Humains , Indicateurs et réactifs , Phénomènes magnétiques , Pandémies , ARN viral/génétique , SARS-CoV-2 , Sensibilité et spécificité
SÉLECTION CITATIONS
Détails de la recherche